Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users

Documenti analoghi

• Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function
  di: Hiroki Nobayashi, et al.
  Pubblicazione: (2026)
• Birth Weight and Labor Market Outcomes: Findings From Tohoku Medical Megabank Data
  di: Midori Matsushima, et al.
  Pubblicazione: (2024)
• Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
  di: Hwa Yeon Ko, et al.
  Pubblicazione: (2025)
• Longitudinal association between the duration of eye gaze fixation on social information and specific symptoms of neurodevelopmental disorders in children: A large‐scale community‐based cohort study
  di: Masatsugu Orui, et al.
  Pubblicazione: (2025)
• Evaluation of depression at 6 and 12 months postpartum by examining depressive symptoms and self‐harm ideation during the early postpartum period: Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study
  di: Masatsugu Orui, et al.
  Pubblicazione: (2024)